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Abstract
A low-energy diet (LED) is an effective approach to induce a rapid weight loss in individuals with overweight. However, reported dispropor-
tionally large losses of fat-freemass (FFM) after an LED trigger the question of adequate protein content. Additionally, not all individuals have the
same degree of weight loss success. After an 8-week LED providing 5020 kJ/d for men and 4184 kJ/d for women (84/70 g protein/d) among
overweight and obese adults, we aimed to investigate the relationship between protein intake relative to initial FFM and proportion of weight lost
as FFM as well as the individual characteristics associated with weight loss success. We assessed all outcomes baseline and after the LED. A total
of 286 participants (sixty-four men and 222 women) initiated the LED of which 82 % completed and 70 % achieved a substantial weight loss
(defined as ≥8 %). Protein intake in the range 1·0–1·6 g protein/d per kg FFM at baseline for men and 1·1–2·2 g protein/d per kg FFM at baseline
for womenwas not associatedwith loss of FFM (P= 0·632). Higher Three-Factor EatingQuestionnaire (TFEQ) hunger at baseline and reductions
in TFEQ disinhibition and hunger during the LEDwere associated with larger weight loss (all P≤ 0·020); whereas lower sleep quality at baseline
predicted less successful weight loss using intention to treat analysis (P= 0·021), possibly driven by those dropping out (n 81, P= 0·067 v. com-
pleters: n 198, P= 0·659). Thus, the protein intakes relative to initial FFM were sufficient for maintenance of FFM and specific eating behaviour
characteristics were associated with weight loss success.
Key words: Low-energy diets: Appetite: Hunger: Behaviour: Protein
The main approach in prevention and treatment of obesity is
promotion of a healthy diet and physical activity. However,
for a large proportion of individuals with overweight and
obesity, it can be very difficult to achieve weight loss through
conventional lifestyle changes alone(1–3). A low-energy diet
(LED) seems to be an effective approach for rapidly inducing
a weight loss pronounced enough to improve cardiometabolic
risk factors(4). To improve cardiometabolic risk factors by weight
loss, primarily loss of fat mass and relative maintenance
of fat-free mass (FFM) are generally seen as beneficial(2).
Additionally, relative maintenance of FFM seems beneficial to
avoid a greater-than-expected drop in resting metabolic rate,
which may impact the maintenance of the weight loss(5–7). An
LED is defined by an energy intake restricted to 3347–5020 kJ/d,
in which a number of formula diets are designed to attain
along with provision of all essential nutrients(8). The formula
diets provide a relatively high protein intake to preserve FFM.
Nevertheless, maintenance of FFM during weight loss may
depend on the protein intake per d (g) during the LED relative
to the individuals’ initial FFM (kg)(6). The protein intake needs to
be sufficient to prevent negative nitrogen balance, which is de-
pendent on the individual’s amount of FFM when initiating the
LED(9). Thereby, it may be beneficial to adjust the protein content
provided per d from the LED dependent on the individual’s FFM
Abbreviations: DXA, dual-energy X-ray absorptiometry; FFM, fat-free mass; ITT, intention-to-treat; LED, low-energy diet; MVPA, moderate-to-vigorous physical
activity; TFEQ, Three-Factor Eating Questionnaire.
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when prescribing a treatment with an LED. Additionally, the
degree of weight loss success obtained with an LED may be de-
pendent onmany different non-nutritional factors(10). Identifying
behavioural characteristics associatedwith individual success on
an LED could be valuable in order to identify the individuals in
need for additional support during an LED and thereby optimise
the individual’s outcome of an LED. Adhering to an LED requires
a substantive effort from the individual, and it is expected that a
high chance of success could be an important factor for motiva-
tion. Furthermore, achieving the possible benefits from a weight
loss may be valuable from a socioeconomic point of view.
Thereby, the ability to predict whether an individual is likely
to obtain a weight loss and the benefits hereof from an LED
may be advantageous to determinewhether it is relevant to dedi-
cate resources for this treatment in order to prevent disease.
Therefore, this study investigated the effect of an 8-week LED
providing 5020 kJ/d for men and 4184 kJ/d for women (84/70 g
protein/d) among overweight adults to induce a successful
weight loss with the two major aims:
• To determine whether individual protein intake (g pro-
tein/d per kg FFM at baseline) from the LED was asso-
ciated with the proportion of weight lost as FFM.
• To determine potential behavioural characteristics asso-
ciated with the degree of weight loss success with an
LED. These evaluations included measures of eating
behaviour, physical activity, sleep and stress at baseline
as well as changes during the LED.
Methods
This paper comprises data collected during an LED carried out
as a part of the European Union (EU) project Satiety
Innovation (SATIN) work package 5. This was a multi-centre
study including participants from Denmark (Copenhagen),
Spain (Reus) and England (Liverpool). The main objective was
to examine if consumption of food products designed to reduce
appetite was associated with improved weight loss maintenance
following an initial weight loss of at least 8 % achieved through
an 8-week LED. At least 8 % weight loss was required during the
LED in order to allow subsequent assessment of weight lossmain-
tenance. This paper presents data from the LED period only.
Study participants
Men and women with overweight or obesity but otherwise
healthy were recruited for the study based on advertisement
through different media sources. Participants met inclusion
criteria if they were aged between 20 and 65 years, had
BMI ≥27·0 and ≤35·0 kg/m2 and fat mass ≥ 23 % (assessed
by bio-impedance).
Exclusion criteria included contraindications related to the
use of the LED or the study products used during the weight loss
maintenance period: allergy and/or intolerance for components
of the LED products and/or study products used during the
weight loss maintenance period, dislike of the LED products
and/or study products for the weight loss maintenance period,
known diseases which may affect energy expenditure and/or
appetite, dietary patterns interfering with the study protocol
(e.g. vegetarians who would be unable to consume the standar-
dised meals at appetite probe days during the weight loss main-
tenance period), body weight changes ±3 kg in the last three
months prior to inclusion, engagement in strenuous exercise
≥5 h/week, smoking or smoking cessation within the past 3
months and/or nicotine use (including electronic cigarettes),
pregnancy or lactation, diabetes mellitus, CVD, systolic blood
pressure above 160 mmHg and/or diastolic blood pressure
above 100 mmHg whether on or off treatment for hypertension
(if treated, the treatment should have been stablewithin the last 3
months when included), chronic kidney disease, liver disease,
active inflammatory bowel disease, coeliac disease, chronic pan-
creatitis or other disorder potentially causing malabsorption,
cancer (active malignant cancer or history of malignancy within
the last 5 years), previous bariatric surgery, history of extensive
small or large bowel resection, known endocrine origin of
obesity (except for stably treated hypothyroidism), transmissible
blood-borne diseases, any recent surgical procedure not fully
recovered, use of prescription medication or use within the pre-
vious month that has the potential of affecting body weight, Hb
concentration below local laboratory reference values, regular
consumption of alcohol above recommendations; >21 alcoholic
units/week for men or >14 alcoholic units/week for women,
drug abuse, psychological or psychiatric disorders possible to
interfere with the study.
The study was carried out in accordance with Good Clinical
Practice and the study protocol and study forms complied
with the relevant sections of the Declaration of Helsinki.
Participants received written and oral information about the
study and written informed consent was obtained before
any study-related procedures were initiated. Recruitment and
testing took place at the Department of Nutrition, Exercise
and Sports, University of Copenhagen, Denmark between
January and November 2016, the Department of Biochemistry
and Biotechnology, University Rovira i Virgili; Institute of
Health IISPV; The Spanish Biomedical Research Centre in
Physiopathology of Obesity and Nutrition (CIBERobn), ISCIII
between January and December 2016 and the Department of
Psychological Sciences, Institute of Psychology, Health and
Society, University of Liverpool between April 2016 and July
2017. The study was approved by the Municipal Ethical
Committee of Copenhagen/Scientific Ethics Committee of the
Metropolitan regions of Denmark (journal no. H-15008553),
the Danish Data Protection Agency (journal no. 2015-57-0117),
the Clinic Investigation Ethical Committee of the Hospital
University Sant Joan de Reus (journal no. 15-07-30/7assN2);
sponsorship was obtained from University of Liverpool (refer-
ence: UoL001153) and related ethical approval from Preston
NRESCommittee NorthWest (health research authority) (journal
no. 16/NW/0135) and was registered on www.clinicaltrials.gov;
ID NCT02485743. All study procedures were aligned between
sites before initiation of the study and on-site monitoring visits
were carried out by an independent monitor.
Visits
The study comprised of a screening visit and additionally sixteen
visits to the study facilities. This paper includes data from the first
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eight of these visits, which were related to the LED (Fig. 1). After
providing informed consent, screening visits (visit 1) were
scheduled identifying participants eligible for inclusion. At the
first study visit (visit 2), taking place within 4 weeks from the
screening visit, baseline measurements were performed. No
more than 10 d after the baseline measurements, the participants
consulted a dietitian at a group session where the LEDwas intro-
duced and initiated. During the LED, the participants met every
second week at group sessions for weighing, provision of the
formula diet and for support from each other and the dietitian
(visits 3–6). The LED was completed after the fifth group session
(visit 7; 8 weeks after initiation of the LED), at which point the
weight loss percentage was calculated for each individual.
After 7–10 d of stabilisation to a normal diet, all participants (also
those achieving <8 % weight loss and thereby no longer
included in the study) were invited for the post-LED measure-
ments (visit 8). The stabilisation period served to regain normal
muscle glycogen stores in order to avoid affecting body compo-
sition and to stabilise blood parameters to avoid potential effects
of an ongoing negative energy balance.
Low-energy diet
During the 8-week LED, men were assigned to consume
5020 kJ/d and women 4184 kJ/d, that is, six and five serv-
ings/d of Modifast® (Nutrition et Santé SAS) formula diet (pro-
vided as shakes, mousses and soups). The macronutrient
composition of the diet was about 20 % energy from fat, about
25 % energy from protein and about 55 % energy from carbo-
hydrate, varying slightly depending on the specific products
consumed. Hence, the daily protein intakes were about 84
and 70 g for men and women, respectively, assuming 100 %
compliance to the prescribed formula diet.
The participants were instructed thoroughly how to prepare
the products. Along with the LED, the participants were allowed
to drink coffee and tea without milk and sugar, drink water and
artificially sweetened soft drinks, chew/eat sugar-free chewing
gum or pastilles (no more than six pieces/d), and to eat a maxi-
mum of 375 g vegetables high in water and low in fibre such as
cucumbers, tomatoes and lettuce. Dietitians ensured compliance
with the prescribed diet based on the participants’ diaries.
Anthropometric measurements
Body weight while wearing light clothing and having emptied
the bladder was measured to the nearest 0·1 kg on calibrated
scales (Copenhagen: Lindell Tronic 8000, Samhall Lavi; Reus:
Tanita SC-331S, Tanita Corporation of America Inc.; Liverpool:
Seca 799 Electronic Column Scales Class (lll)) in a fasting condi-
tion at screening, baseline and post-LED (visits 1, 2 and 8: Fig. 1),
in a non-fasting condition at the group sessions (visits 3–6: Fig. 1)
and in a semi-fasted state (minimum 4 h) at the last group session
assessing the percentage weight loss (visit 7: Fig. 1). At baseline,
height without shoes was measured to the nearest 0·5 cm using
wall-mounted stadiometers (Copenhagen and Reus: Seca;
Liverpool: Seca 220 Telescopic Measuring Rod). BMI was calcu-
lated with the formula: body weight [kg]/(height[m])2. Body
composition measured at baseline and post-LED was deter-
mined by dual-energy X-ray absorptiometry (DXA) (GE Lunar
iDXA, Encore software: Copenhagen and Liverpool: version
16.2; Reus version 13.4). Waist and hip circumferences while
wearing light clothingweremeasured to the nearest 0·5 cm using
a non-elastic tape measure. The waist circumference was mea-
sured at the midpoint between the bottom of the rib cage (last
floating rib) and the top of the iliac crest with the measuring tape
around the trunk in a horizontal plane. The hip circumference
was measured at the widest point between the hips and but-
tocks. Once the measuring tape was placed, the participants
were asked to relax with both arms at his/her side and to breathe
normally in order to take each measurement on the exhales(11).
Blood pressure and biochemical measurements
Calibrated automatic devices were used for themeasurements of
blood pressure (Copenhagen: A&D Medical UA-779; Reus:
Omron 705IT; Liverpool: Omron 705 CP-II). The participants
were asked to empty their bladder and were placed in a resting
position for 5–10 min prior to the measurements. To minimise
‘the white coat effect’, the sub-investigator measuring the blood
pressure stayed in the room when the participants were resting.
Appropriate arm cuffs were placed at participants’ right arm in
direct contact with the skin. The measurements were recorded
to the nearest 1 mmHg.
Blood samples were collected from the antecubital vein with
the participant in at least 10 h of fasting state (besides amaximum
of 500 ml of water) and after at least 5-min rest and in a supine
position. The blood samples were analysed for glucose, insulin,
total cholesterol, HDL, LDL, VLDL, TAG, alanine-aminotransfer-
ase, aspartame-aminotransferase, γ-glutamyl-transferase, leptin,
C-reactive-protein, adiponectin and IL-6. Plasma was obtained
by centrifugation at 1800 g for 15 min at 4°C and stored at
−80°C until use. All parameters were determined by routine
laboratory tests using standardised protocols.
Fig. 1. Overview of the study design and data collection involved in the seven visits that include data related to the low-energy diet period. The participants followed the
low-energy formula diet from week 1 (visit 3) to week 9 (visit 7). DXA, dual-energy X-ray absorptiometry.
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Measures of behavioural characteristics
Self-administrated questionnaires assessing behavioural char-
acteristics were handed out for the participants to complete in
relation to the study visits at baseline and after completing the
LED. The participants could complete the questionnaires at
home right before or after the study visits. A standard front
page, layout and introduction text was attached and the ques-
tions were always presented in the same order as in the vali-
dated versions.
Eating behaviour
Eating behaviour was assessed by the validated Three-Factor
Eating Questionnaire (TFEQ), including fifty-one questions
related to appetite and eating behaviour generating scores
of: restraint (cognitive control of the frequency, amount and
types of food being eaten); disinhibition (lack of control over
eating behaviour in spite of conscious awareness hereof);
hunger (susceptibility to hunger)(12). The minimum to maxi-
mum score is 0–21, 0–16 and 0–14 for restraint, disinhibition
and hunger, respectively(12).
Physical activity and sleep
Participants were asked to wear an ActiGraph™ tri-axis acceler-
ometer monitor (GT3Xþ) tightly on the right hip using an elastic
belt for seven consecutive days and eight nights (entire 24-h
period). They were only allowed to remove the accelerometer
during water activities (i.e. showering or swimming). At the
end of the observation period, data were reintegrated to 60-s
epochs and analysed using ActiLife6 (the ActiGraph 2012,
ActiLife version 6). Participants were instructed to keep logs
for bedtime (‘lights off’ and ’trying to sleep’) and waking time
(‘lights on’) during the week in which the accelerometer
was worn.
Before analysis of physical activity and sedentary time, we
removed self-reported sleep duration as well as non-wear
time defined as 60 min of consecutive zeros using vector mag-
nitude, allowing for 2 min of non-zero interruptions with a
maximum of 100 counts/min (CPM). Total physical activity
(CPM) was expressed as vector magnitude of the total tri-axial
counts from monitor wear time divided by monitor wear time.
Time spent in a sedentary state, doing light physical activity
and moderate-to-vigorous physical activity (MVPA) were
defined as all min showing <200, 200–2689 and ≥2690 vector
magnitude CPM, respectively(13). The weekly averages of total
physical activity, MVPA and sedentary time were calculated in
the proportion of five to two between weekdays (Monday to
Friday) and weekend days (Saturday and Sunday) and were
only considered valid if monitor wear time was at least
10 h/d (excluding sleep duration) for a minimum of one week-
day and one weekend day.
To estimate accelerometer-determined sleep duration, the
self-reported bedtimes and waking times were used as the pos-
sible window of sleep and accelerometer data within this win-
dow were scored in ActiLife6 using the algorithm by Sadeh
et al.(14). The weekly average of sleep duration was calculated
in the proportion of five to two between weekdays (Sunday
to Thursday) and weekend days (Friday and Saturday). Sleep
duration was only considered valid if it was measured for a mini-
mum of one weekday and one weekend day. The intra-partici-
pant standard deviation of the sleep duration was used to
represent sleep variability. Sleep duration estimated from the
hip has been found to correlate well with that estimated from
the wrist(15).
Sleep quality was estimated through the validated Pittsburgh
Sleep Quality Index (PSQI)(16). The PSQI estimates long-term sleep
habits during the past month based on nineteen self-rated ques-
tions. These nineteen items are combined to form seven compo-
nent scores; each of which has a range from 0 to 3 points. In all
cases, a score of ‘0’ indicates no sleep difficulty, while a score of
‘3’ indicates severe difficulty. The seven component scores are then
added to yield one global score,with a range of 0–21 points, ‘0’ indi-
cating no difficulty and ‘21’ indicating severe difficulties in all
areas(16).
Level of stress
Level of stress was estimated through the Perceived Stress Scale
(PSS)(17). The PSS estimates long-term perceived stress and mea-
sures stress related to emotions and thoughts the preceding
month through ten questions. Each question has five possible
answers resulting in a summed score across all scale items with
‘0’ indicating no perceived stress(17).
Statistical analyses
Baseline characteristics were summarised using means with
standard deviations.
To assess the degree of weight loss success, linear mixed
models were fitted including adjustment for visit, age and
baseline BMI (fixed effects) as well as participant and site
(random effects). Since body weight developments were dif-
ferent for men and women, separate analyses were carried out
for assessing the LED efficacy and efficiency. Since the post-
LED data represent a somewhat selective group (explained in
the flow chart: Fig. 2), two analyses of body weight were car-
ried out: (1) all participants completing the LED; (2) intention-
to-treat (ITT) analysis of all participants initiating the LEDwith
last observation carried forward for those not completing the
LED or not attending the post-LED measures. ITT analyses
were only done for body weight. Some participants did lose
weight but were not DXA scanned, etc. afterwards.
Thereby, it would not be representative to carry the baseline
measure of, for example, body composition forward.
To assess the two aims investigated, linear mixed models
were fitted including adjustment for age and baseline BMI (fixed
effects) as well as site (random effect). Associations between
behavioural characteristics and degree of weight loss success
were analysed combined for men and women but adjusted for
sex (fixed effect).
As age and baseline BMI was expected to influence weight
loss and the potential effects seen from the weight loss, all analy-
ses were adjusted for these two variables.
For all models, assumptions of normality and homogeneity
of variance were assessed through visual inspection of histo-
grams and quantile–quantile plots and plots of residuals
Predictors of weight loss on a low-energy diet 471
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against the fitted values. Results are shown as means with 95 %
CI. Statistical analyses were carried out using Stata/SE 15
(StataCorp). Statistical significance was declared using a sig-
nificance level of 0·05.
Results
Study population
From the total of 374 participants who responded to the advertise-
ments, 301 participants were eligible for inclusion, but twelve
dropped out prior to the first study visit resulting in 289 partici-
pants completing the baseline measurements before initiating
the LED. Before initiation of the LED, a total of fifteen participants
dropped out due to unwillingness to comply with the study pro-
tocol and for personal reasons. Thereby, 286 participants initiated
the LED of which sixty-four were men and 222 women. Number
of participants completing each visit is presented in Fig. 2.Of those
initiating the LED,mean agewas 46·0 (SD 10·7) years (range: 20–65
years) and they had a bodyweight of 87·8 (SD 11·2) kg and BMI of
31·1 (SD 2·2) kg/m2.
Table 1 shows baseline characteristics stratified by sex for all
participants initiating the LED. Additionally, Table 2 shows base-
line characteristics, post-LED values and LED changes stratified
by sex for all participants completing the LED and attending the
study visit after the LED.
A total of 199 of the 234 participants completing the 8-week
LED reached the weight loss goal of ≥8 %. Of these, 96 % com-
pleted the post-LED measures, whereas only 17 % of those par-
ticipants achieving <8 % weight loss accepted to complete the
post-LED measures.
Efficacy and efficiency of the low-energy diet to induce a
successful weight loss
For all participants initiating the LED (n 286), 82 % completed
the LED and 70 % achieved weight loss ≥8 %. Of those
completing the LED (n 234), 85 % achieved weight loss ≥8 %.
Weight loss varied between men and women (χ2(6)= 197·4,
P < 0·001). Thus, the changes in body weight, anthropometrics,
cardiometabolic risk factors and behavioural characteristics for
participants completing the LED and attending the post-LED
measures (visit 8: Figs. 1 and 2), are stratified by sex and pre-
sented in Table 2.
For all participants completing the post-LED measures
(n 198), the mean weight loss after 8 weeks of LED (visit 7:
Fig. 1) was 9·4 (95 % CI 9·2, 9·7) kg corresponding to 11
(95 % CI 10, 11) %. After the stabilisation period (visit 8: Fig. 1),
the weight loss was 9·3 (95 % CI 9·0, 9·5) kg, of which 7·1
(95 % CI 6·8, 7·5) kg was loss in fat mass and 1·6 (95 % CI 1·4,
1·9) kg was loss in FFM.
For all the participants that initiated the LED and with last
observation carried forward for those not completing the
Fig. 2. Flow chart of participants completing each visit. LED, low-energy diet.
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LED or not attending the post-LED measures (n 286), the
weight loss after 8 weeks of LED (visit 7: Fig. 1) was 7·6
(95 % CI 7·3, 7·9) kg corresponding to 8 % (ranging from
−2 to 19 %). After the stabilisation period (visit 8: Fig. 1), the
weight loss was 7·5 (95 % CI 7·2, 7·8) kg.
Changes in body weight for the participants completing the
LED and for the participants initiating the LED divided by all
the visits measuring body weight is illustrated in Fig. 3 for
men and women, respectively.
Relationship between protein intake relative to initial
fat-free mass and proportion of weight lost as fat-free
mass
Median protein intake was 1·3 (range 1·0–1·6) g protein/d per kg
FFM at baseline for men (n 49) and 1·5 (range 1·1–2·2) g protein/d
per kg FFM at baseline for women (n 137). Mean percentage
proportion of weight lost as FFM was 17 (95 % CI 14·6, 19·2) %
(men: 19 (95 % CI 15·9, 22·2) %; women: 16 (95 % CI 13·3,
19·1) %). No relationship between protein intake/d per kg
FFM at baseline and proportion of weight lost as FFM was
found (P = 0·64) (Fig. 4). Data were analysed for both sexes
combined since there was neither interaction between sex
and amount of protein/d per kg FFM at baseline
(χ2(1) = 1·43, P = 0·2314) nor impact of adjustments for sex
(χ2(1) = 0·75, P = 0·39). Only three participants who did not
achieve the ≥8 % weight loss were DXA scanned.
Therefore, the population for this analysis comprised a total
of 186 (forty-nine men and 137 women) participants who
completed the LED with ≥8 % weight loss and attended the
post-LED measures (visit 8: Figs. 1 and 2).
Table 1. Baseline anthropometrics, cardiometabolic risk factors and behavioural characteristics for all participants initiating the low-energy diet (completing
visit 3: Figs. 1 and 2)
(Mean values and standard deviations)
Age (years) (range) : : :
Men (n 64) Women (n 222)
46·8 (SD 10·1) (22–65) 45·8 (SD 10·8) (20–65)
Mean SD Mean SD
Anthropometry Height (m) 1·78 0·1 1·65 0·1
Body weight (kg) 99·1 10·8 84·6 9·0
BMI (kg/m2) 31·2 1·8 31·1 2·3
Fat mass (DXA, kg) 34·2 5·3 37·3 5·8
Fat-free mass (DXA, kg) 63·9 7·7 46·4 5·5
Waist circumference (cm) 108·0 7·5 99·0 9·0
Hip circumference (cm) 108·0 6·0 113·0 7·0
Blood pressure Systolic BP (mm/Hg) 132 15 124 15
Diastolic BP (mm/Hg) 82 9 80 10
Biochemical measurements Fasting glucose (mmol/l)* 5·4 0·5 5·1 0·6
Fasting insulin (pmol/l)* 81·4 46·1 66·5 46·8
HOMA-IR* 2·8 1·8 2·2 1·8
Total cholesterol (g/l)* 2·0 0·4 1·9 0·3
HDL-cholesterol (g/l)* 0·5 0·1 0·6 0·2
LDL-cholesterol (g/l)* 1·3 0·4 1·2 0·3
VLDL-cholesterol (g/l)* 0·2 0·1 0·2 0·1
TAG (g/l)* 1·2 0·6 1·0 0·5
ALAT (U/l)* 31·1 15·7 18·3 9·2
ASAT (U/l)* 25·0 8·8 18·9 5·1
GGT (U/l)* 33·7 31·2 20·1 21·8
Leptin (μg/ml)† 3·2 5·0 6·9 8·1
CRP (g/l)† 0·1 0·1 0·1 0·1
Adiponectin (μg/ml)† 7·3 3·6 11·9 7·4
IL-6 (pg/ml)† 2·7 5·9 2·5 3·3
Eating behaviour (TFEQ) Restraint 7 4 10 5
Disinhibition 7 3 8 3
Hunger 5 3 6 3
Physical activity (ActiGraph)‡ Sedentary time (min)§ 566 105 521 129
MVPA (min)§ 58 30 53 29
TPA (CPM)§ 601 189 623 191
Sleep‡ Duration (ActiGraph, min)|| 425 48 444 57
Variability (ActiGraph, min)|| 63 26 63 32
Quality (PSQI) 6 3 6 3
Stress (PSS) 13 7 14 7
DXA, dual-energy X-ray absorptiometry; BP, blood pressure; HOMA-IR, homeostatic model assessment-insulin resistance; ALAT, alanine-aminotransferase; ASAT, aspartame-
aminotransferase; GGT, γ-glutamyl-transferase; CRP, C-reactive-protein; TFEQ, Three-Factor Eating Questionnaire (high scores indicate less control of eating behaviour); MVPA,
moderate to vigorous physical activity; TPA, total physical activity; CPM, counts/min; PSQI, Pittsburgh SleepQuality Index (high scores indicate worse sleep quality); PSS, Perceived
Stress Scale (high scores indicate more stress).
* Blood samples only obtained from 8/15 men and 20/41 women from the English site.
† Samples from forty-nine men and 181 women only from the Danish and Spanish sites.
‡ The accelerometer was worn for a mean of 7 (SD 1) d and 7 (SD 1) nights with a wear-time of 966 (SD 98) min/d between wake up and bedtime.
§ Valid data from fifty-one men and 184 women.
|| Valid data from forty-six men and 167 women.
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Relationship between behavioural characteristics and
changes in body weight and body composition
For all participants completing the LED (n 198), one unit higher
hunger score at baseline (reported range: 0–14)was associatedwith
a mean larger weight loss of 0·14 (95 % CI 0·02, 0·26) kg (R −0·46,
P= 0·020). None of the other pretreatment behavioural character-
istics seemed to be related to the changes in body weight or body
composition during the LED (all P > 0·17) (Table 3).
For all the participants who initiated the LED and with last
observation carried forward for those not completing the LED
(n 286), one unit lower sleep quality at baseline (reported range:
1–15) was associated with −0·16 (95 % CI −0·02, −0·30) kg less
weight loss (R 0·36, P= 0·021) (Table 3). Among those dropping
out (n 81), one unit lower sleep quality at baseline (reported
range: 1–18) tended to be associated with −0·18 (95 % CI
−0·37, 0·01) kg less weight loss (R 0·26, P= 0·067).
Table 2. Anthropometrics, cardiometabolic risk factors and behavioural characteristics before and after the low-energy diet (LED) along with changes for all
participants completing the LED and attending the post-LED measures (visit 8: Figs. 1 and 2)
(Mean values and standard deviations; mean values and 95 % confidence intervals)
Baseline Post-LED Change after 8 weeks LED†
Men (n 50)
Women
(n 148) Men (n 50)
Women
(n 148) Men Women
Mean SD Mean SD Mean SD Mean SD Mean 95 % CI Mean 95 % CI
Anthropometry Body weight (kg) 99·0 10·0 84·9 8·8 87·9 9·6 76·3 8·0 −11·2*** −10·7, −11·7 −8·6*** −8·3, −8·9
BMI (kg/m2) 31·2 1·8 31·0 2·2 27·7 2·1 27·9 2·1 −3·5*** −2·7, −4·3 −3·1*** −2·6, −3·6
Fat mass (DXA, kg) 33·5 5·1 37·1 5·4 25·1 5·3 30·5‡ 5·3 −8·3*** −6·9, −9·8 −6·6*** −5·8, −7·5
Fat-free mass (DXA, kg) 64·4 7·1 46·9 5·6 62·2 7·2 45·4‡ 5·4 −2·1* −0·1, −4·1 −1·5* −0·3, −2·6
Waist circumference (cm) 108·0 7·0 98·5 8·5 97·0 7·5 89·5 8·0 −11·0*** −8·5, −13·5 −9·0*** −7·6, −10·5
Hip circumference (cm) 107·5 6·0 113·0 6·0 101·0 5·0 106·5 6·0 −6·2*** −4·4, −8·1 −6·4*** −5·3, −7·5
Blood pressure Systolic BP (mm/Hg) 131 15 124 15 126 14 119 13 −5* 0, −10 −5*** −3, −8
Diastolic BP (mm/Hg) 81 9 80 10 77 9 75 9 −4** −1, −8 −5*** −3, −6
Biochemical
measurements
Fasting glucose
(mmol/l)§
5·4 0·4 5·3 0·7 5·2 0·4 5·1 0·5 −0·2* −0·4, 0·0 −0·2* −0·1, −0·3
Fasting insulin (pmol/l)§ 78·4 43·1 64·6 43·1 50·6 30·7 45·0 27·8 −27·7*** −14·1, −41·4 −19·7*** −11·8, −27·5
HOMA-IR§ 2·7 1·6 2·3 1·7 1·7 1·1 1·5 1·0 −0·7*** −0·4, −1·0 −1·0*** −0·5, −1·6
Total cholesterol (g/l)§ 2·0 0·4 2·0 0·3 1·8 0·3 1·8 0·3 −0·2** −0·1, −0·4 −0·2*** −0·1, −0·3
HDL-cholesterol (g/l)§ 0·5 0·1 0·6 0·2 0·5 0·1 0·5 0·1 0·0 −0·1, 0·1 −0·1*** −0·1, 0·0
LDL-cholesterol (g/l)§ 1·3 0·4 1·2 0·3 1·1 0·3 1·1 0·3 −0·2** −0·1, −0·3 −0·1** −0·1, −0·2
VLDL-cholesterol (g/l)§ 0·2 0·1 0·2 0·1 0·2 0·1 0·2 0·1 −0·1* −0·1, 0·0 −0·1* −0·1, 0·0
TAG (g/l)§ 1·2 0·6 1·0 0·5 1·0 0·4 0·9 0·3 −0·2* −0·1, −0·4 −0·1* −0·1, −0·2
ALAT (U/l)§ 31·8 16·5 19·3 9·9 21·1 8·0 19·2 17·9 −10·8*** −5·0, −16·6 −0·2 −3·5, 3·2
ASAT (U/l)§ 25·8 9·8 19·5 5·1 21·2 6·8 19·2 9·7 −4·6* −1·4, −7·9 −0·3 −2·2, 1·5
GGT (U/l)§ 33·6 32·2 21·7 20·9 21·4 16·9 18·3 19·7 −12·2** −3·4, −21·0 −3·3 −8·4, 1·7
Leptin (μg/ml)|| 2·7 3·1 6·7 7·5 2·7 1·9 3·9 4·3 −1·3 −3·6, 0·9 −2·9*** −1·6, −4·2
CRP (g/l)|| 0·1 0·1 0·1 0·1 0·0 0·0 0·0 0·0 0·0 −0·1, 0·1 −0·1* −0·1, 0·0
Adiponectin (μg/ml)|| 7·0 3·4 12·0 7·8 8·5 3·9 11·9 6·5 1·5 −1·2, 4·2 −0·1 −1·6, 1·4
IL-6 (pg/ml)|| 2·8 6·4 2·0 1·4 1·8 2·5 2·0 1·5 −1·0 −2·2, 0·2 −0·1 −0·7, 0·6
Eating behaviour
(TFEQ)
Restraint 7 4 10 5 11 4 13 5 4·4*** 2·7, 6·1 3·3*** 2·3, 4·3
Disinhibition 7 3 8 3 6 3 7 3 −0·6 −1·8, 0·6 −0·8* −0·1, −1·6
Hunger 5 3 6 3 5 4 5 3 −0·4 −1·7, 0·9 −1·0* −0·2, −1·7
Physical activity
(ActiGraph)¶
Sedentary time (min)†† 568 96 542 124 538 100 519 118 −30 −75, 16 −23 −49, 3
MVPA (min)†† 58 31 50 27 60 22 57 32 2 −10, 14 7* 0, 14
TPA (CPM)†† 591 189 583 186 628 154 637 207 37 −37, 111 54* 12, 96
Sleep¶ Duration (ActiGraph,
min)‡‡
425 49 434 44 432 51 443 47 7 −13, 28 9 −3, 20
Variability
(ActiGraph, min)‡‡
62 26 62 28 64 33 57 28 2 −11, 15 −5 −12, 2
Quality (PSQI) 5 2 6 3 4 3 6 3 −0·8 −2·0, 0·4 −0·3 −1·0, 0·4
Stress (PSS) 12 6 14 6 10 6 11 6 −1·4 −3·8, 1·0 −2·3** −3·7, −0·9
DXA, dual-energy X-ray absorptiometry; BP, blood pressure; HOMA-IR, homeostatic model assessment-insulin resistance; ALAT, alanine-aminotransferase; ASAT, aspartame-
aminotransferase; GGT, γ-glutamyl-transferase; CRP, C-reactive-protein; TFEQ, Three-Factor Eating Questionnaire (high scores indicate less control of eating behaviour); MVPA,
moderate to vigorous physical activity; TPA, total physical activity; CPM, counts/min; PSQI, Pittsburgh Sleep Quality Index (high scores indicate worse sleep quality); PSS, Perceived
Stress Scale (high scores indicate more stress).
Significance of mean value of change from baseline to post-LED: *P < 0·05, **P < 0·01, ***P < 0·001.
† Changes in all measurements assessed at baseline (visit 2) to post-LED (visit 8) were analysed by linear mixed models including adjustment for visit, age and baseline BMI (fixed
effects) as well as participant and site (random effects).
‡ Data from 139 women.
§ Data available from forty-four men and 133 women.
|| Samples from forty-one men and 125 women only from the Danish and Spanish sites.
¶ The accelerometer was worn for a mean of 7 (SD 1) d and 7 (SD 1) nights with a wear-time of 966 (SD 98) min/d between wake up and bedtime at baseline and 7 (SD 1) d and 7 (SD 1)
nights with a wear-time of 958 (SD 87) min/d between wake up and bedtime post-LED.
†† Valid data from forty men and 126 women.
‡‡ Valid data from thirty-seven men and 116 women.
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A one-unit reduction in scores of disinhibition (reported
range: 1–15) and hunger during the LED were associated with
a larger weight loss (0·24 (95 % CI 0·09, 0·39) kg, R 0·48,
P= 0·002; 0·25 (95 % CI 0·13, 0·38) kg, R 0·49, P < 0·001)
(Fig. 5). Grouping changes in the eating behaviour scores into
quartiles further revealed that participants who had decreasing
scores of disinhibition and hunger the most during the LED
obtained 1·4 (95 % CI 0·3, 2·5) kg (R 0·50, P= 0·010) and 2·0
(95 % CI 1·0, 2·9) kg (R 0·52, P < 0·001) greater weight loss com-
pared with those in the lowest 25th percentile. Additionally, a
higher hunger score at baseline was associated with a 0·35
(95 % CI 0·23, 0·47) unit reduction in hunger score during the
LED (R −0·40, P < 0·001). No changes in any of the other behav-
ioural characteristics were related to the changes in body weight
or body composition (all P > 0·10, data not shown).
Discussion
A total of 70 % of the participants managed to lose a minimum of
8% of initial bodyweight with only 17% of theweight loss due to
loss of FFM. For the participants completing the LED, the propor-
tion of weight lost as FFM was not dependent on the protein
intake relative to initial FFM. The individuals that lost the most
body weight during LED were characterised by higher TFEQ
hunger at baseline and greater reductions in TFEQ disinhibition
and hunger during the LED. Additionally, lower sleep quality at
baseline predicted less successful weight loss with LED using the
ITT analysis, possibly driven by those dropping out.
The results on weight loss correspond with previous findings
on the efficacy of LED(18–20). Moreover, the weight loss resulted
in clinically relevant improvements in the cardiometabolic risk
factors. As an example, 60 % of the forty-two participants char-
acterised as prediabetic at baseline became normoglycaemic
after the LED(21). Our results confirm that similar degrees ofweight
loss and magnitudes of health improvements can be obtained
with less energy restriction(18,20). Additionally, Nielsen et al.(19)
showed that energy restriction providing 4184 kJ/d for 7 weeks
to obese individuals, corresponding to provision of 1·0 g
protein/d per kg FFM at baseline, resulted in a 39 % share of
weight lost as FFM. Papadaki et al.(20) showed that energy
Fig. 3. Body weight change from each visit for men and women, respectively. Values are means, with standard errors represented by vertical bars. Intention-to-treat
(ITT) analyses with last observation carried forward for those not completing the low-energy diet (LED) or not attending the post-LED measures.
Fig. 4. Relationship between protein intake relative to initial fat-free mass (FFM) and relative loss of FFM. The linear mixedmodel was fitted including adjustment for age
and baseline BMI (fixed effects) as well as site (random effect). No relationship between baseline FFM and proportion of weight lost as FFM was found (P= 0·632).
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restriction providing 3347 kJ/d for 8 weeks in overweight/obese
individuals, corresponding to provision of 0·9 g protein/d per kg
FFM at baseline, resulted in a 25 % share of weight lost as FFM. In
line with previous findings(22), our results indicate that more FFM
is retained with less energy restriction, possibly due to the con-
comitant higher supply of protein. Furthermore, energy and
thereby protein provided in our study varied between men and
women; thus, to some extent we accounted for sex differences
in FFM when initiating the LED. Nevertheless, our results showed
that the proportion of weight lost as FFM did not seem to be de-
pendent on the amount of protein provided/d per kg FFM when
initiating the LED. All participants in our studywere providedwith
>1 g protein/d per kg FFM when initiating the LED. This suggests
that when a minimum amount of protein is provided/d per kg
FFM, there is no relationship between protein provided/d per
kg FFM when initiating an LED and proportion of weight lost
as FFM. This does not mean that protein intake during a weight
loss period, and especially during an LED, is not important in
order to maintain FFM. Rather our results indicate that a daily
protein intake of about 84 and 70 g/d for men and women,
respectively, is sufficient for a population with BMI ≥27·0 and
≤35·0 kg/m2. This is in agreement with the European Food
Safety Authority (EFSA) expert opinion on the essential composi-
tion of LED during total diet replacement(23). Previous studies
using LED with energy restriction comparable with our study
reported more substantial loss of FFM than we found(24–26).
Table 3. Pretreatment behavioural characteristics and changes in body weight and body composition†
(Mean values and 95 % confidence intervals)
ΔWeight (kg)
(intention-to-treat
analyses: n 286)
ΔWeight (kg)
(n 198)
ΔFat mass (kg)
(n 189)
ΔFat-free mass (kg)
(n 189)
Mean 95 % CI Mean 95 % CI Mean 95 % CI Mean 95 % CI
Eating behaviour (TFEQ) Restraint −0·03 −0·14, 0·07 0·04 −0·04, 0·12 0·01 −0·06, 0·08 0·03 −0·02, 0·07
Disinhibition −0·02 −0·16, 0·12 −0·06 −1·73, −3·48 −0·03 −0·13, 0·07 0·02 −0·05, 0·09
Hunger −0·08 −0·21, 0·05 −0·14* −0·02, −0·26 −0·07 −0·16, 0·02 −0·01 −0·08, 0·05
Physical activity
(ActiGraph)‡
Sedentary time (min) −0·01§ −0·01, 0·01 0·01|| −0·01, 0·01 0·01 −0·01, 0·01 0·01 −0·01, 0·01
MVPA (min) −0·01§ −0·02, 0·01 −0·01|| −0·02, 0·01 −0·01 −0·02, 0·01 0·01 −0·01, 0·01
TPA (CPM) 0·01§ −0·01, 0·01 −0·01|| −0·01, 0·01 −0·01 −0·01, 0·01 0·01 −0·01, 0·01
Sleep‡ Length (ActiGraph) 0·01¶ −0·01, 0·02 −0·01†† −0·01, 0·01 0·01 −0·01, 0·01 −0·01 −0·01, 0·01
Variability (ActiGraph) −0·01¶ −0·01, 0·02 0·01†† −0·01, 0·02 0·01 −0·01, 0·01 0·01 −0·01, 0·01
Quality (PSQI) 0·16* 0·02, 0·30 0·03 −0·10, 0·16 −0·02 −0·12, 0·09 0·01 −0·07, 0·08
Stress (PSS) 0·05 −0·01, 0·12 0·05 −0·01, 0·12 −0·02 −0·07, 0·02 0·01 −0·02, 0·05
TFEQ, Three-Factor Eating Questionnaire; MVPA, moderate to vigorous physical activity; TPA, total physical activity; CPM, counts/min; PSQI, Pittsburgh Sleep Quality Index; PSS,
Perceived Stress Scale.
* P < 0·05.
†Data are presented as unstandardised regression coefficients (β) and 95%CI using linearmixedmodels including adjustment for age, sex and baseline BMI (fixed effects) aswell as
site (random effect).
‡ The accelerometer was worn for a mean of 7 (SD 1) d and 7 (SD 1) nights with a wear-time of 966 (SD 98) min/d between wake up and bedtime at baseline and 7 (SD 1) d and 7 (SD 1)
nights with a wear-time of 958 (SD 87) min/d between wake up and bedtime post-LED.
§ Valid data from 235 participants.
|| Valid data from 172 participants.
¶ Valid data from 213 participants.
†† Valid data from 157 participants.
Fig. 5. Relationship between changes in eating behaviour scores and changes in body weight. (a) Changed score of disinhibition (R 0·48,P= 0·002); (b) changed score
of hunger (R 0·49,P< 0·001). A negative score equals less disinhibition/less hunger. Linear mixedmodels were fitted including adjustment for age, baseline BMI and sex
(fixed effects) as well as site (random effect).
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However, the previous findings may, to some degree, be affected
by the time of assessment of body composition. Following an
LED, glycogen storages are depleted; thus, the body retains less
intramuscular water as compared to when glycogen storages
are filled(27). Therefore, body composition after LED should be
assessed after a period of stabilisation to a normal diet, and the
proportion of FFM lost during an LED may not be as high as pre-
viously shown, at least not when>1 g protein/d per kg FFMwhen
initiating the LED is provided. Since there is a relatively large varia-
tion in amount of FFM loss in different studies(22), it remains inter-
esting to investigate whether accounting for different protein
needs canminimise FFM loss during an LED. Aswe already some-
what accounted for this in our study by providing different energy
and thereby different amount of protein for men and women, it
remains likely that accounting for individual protein needs within
the LEDcanbebeneficial in order to retain FFM, especially the less
energy that is provided.
A higher score of hunger derived from the TFEQ at baseline
was found to explain 21 % of the variation in weight loss and
thereby predicted a larger weight loss. Based on this result,
we hypothesise that for those individuals with a high level of
hunger, hunger to a large degree controls their energy intake
making them susceptible to overconsumption. We further
hypothesise that hunger is somewhat ‘disconnected’ during an
LED as the energy intake is controlled by a strict set of prescribed
rules for adhering to the LED. Thereby, individuals with an eating
behaviour driven by hunger can be expected to benefit the most
from the disciplines of the LED and thereby achieve a larger
weight loss. Overall, we hypothesise that dysregulated eating
behaviour is forced to be regulated again because of the pre-
scribed rules from the LED resulting in a larger weight loss.
Different factors motivating an individual to eat may be consid-
ered important in the control of eating behaviour(28), and physio-
logical regulators of appetite is found to be increased after a
weight loss(29–31). Thereby, the ability to change eating behav-
iour, that is, be less responsive to signals of appetite that motivate
the individual to eat, seems likely to be important for the weight
loss success. This is confirmed by our results showing that par-
ticipants with high hunger level when initiating the LED unex-
pectedly reported a decreased hunger after the weight loss.
This indicates that individuals whose eating is driven by their
hunger may be able to control their hunger better during an
LED, which thereby increases the weight loss success.
Decreased perceptions of disinhibition and hunger (observed
when analysing sex together) may be explained by ketosis from
the energy restriction(32). The TFEQ asks the participants about
their recent attitudes towards foods. In this study, the TFEQ
was assessed after stabilisation to a normal diet, but the changes
observed in the eating behaviour indicate that the ketosis from the
diet resulted in decreased perceptions of disinhibition and hun-
ger. Restraint eating was found to be increased after the LED,
probably a result from adhering to the strict rules during the diet.
Thereby, we hypothesise that individuals whose eating is pre-
dominantly driven by factors other than hunger, for example, hab-
its, social settings, liking of food, etc., may benefit from additional
help during the LED in order to achieve a successful weight loss.
From the ITT analyses, lower sleep quality at baseline was
found to explain 13 % of the variation in weight loss and thereby
predicted failure with LED. This result was possibly driven by
those dropping, indicating that lower sleep quality cause individ-
uals to drop out rather than causingweight loss failure. However,
lower baseline sleep quality was previously found to be related
to preintervention BMI Z-score (R −0·49, P= 0·02) after 19 d of
LED in obese adolescents(33). The group by Verhoef have also
shown that change in sleep duration during an 8-week very
low-energy diet (providing 2100 kJ/d) was concomitantly nega-
tively correlatedwith the change in BMI in a population similar to
the one in our study(10). Based on this and as sleep patterns have
also been reported to be linked to lack of interest, motivation and
energy, it seems likely that lower sleep quality may result in fail-
ure with LED(34). Thus, it may be relevant to consider the individ-
ual’s perceived sleep quality before recommending an LED, as
the individual’s motivation to comply with an LED may be de-
pendent hereof.
Changes in physical activity level, sleep patterns or level of
stress do not seem to be associated with weight loss success.
Our results on physical activity showed that women increase
MVPA by 14 % and total physical activity by 9 %; however, no
relationship was found between changes in physical activity
and weight loss success. These results confirm similar findings
in studies investigating the effect of physical activity during
energy restriction, which found no additional weight loss when
increasing physical activity during LED(35). Moreover, in our
study, women’s average level of stress also decreased by
17%, but thiswas not found tobe related to theweight loss success.
Similar sex differences in stress response toenergy restrictions have
been found in rats, which responded equally to the energy restric-
tion in weight development, confirming no relationship between
level of stress and weight loss success(36).
Based on our results, relationships between eating as well as
sleep behaviour and weight loss success remain likely. It seems
especially interesting to investigate different characterisations of
eating behaviour further. To our knowledge, these relationships
have not been investigated previously and they remain interest-
ing to investigate with different weight loss interventions.
Strengths and limitations
High completion rate strengthens the conclusion, which is based
on results from the majority of the participants initiating the
study. However, the results are limited by the fact that most of
the participants not achieving the≥8%weight loss were unwilling
to attend the post-LED measures. The results on relationship
between protein intake relative to initial fat-free mass (FFM) and
proportion of weight lost as FFM may have been biased since
the analysis necessitated to only include those who succeeded
to achieve the ≥8 % weight loss. Nevertheless, those achieving
≥8 % weight loss are expected to represent the part of the
study population having the biggest loss of FFM. Thus, excluding
those failing to achieve ≥8 % weight loss is not expected to have
affected the outcome showing that the amount of proteinprovided
per d during this LED was sufficient for relative preservation
of FFM.
The TFEQ is a validated measure with each domain found to
correlate well with eating behaviour. For further investigations,
standardised appetite probe days assessing ad libitum energy
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intake alongwith subjective ratings of appetite and eating behav-
iour would be interesting measures to include in order to study
eating behaviour pre and post LED.
Physical activity was assessed by both objective and subjec-
tive measures. Due to ethical constraints, one of the study sites
was only able to include wearing of the Actigraph (objective
measure of physical activity) and also collection of blood sam-
ples as optional. Thereby, only few participants from the
English site contributed with these data resulting in less power
and uneven representation of data from each site. Also, dropout
rate varied a lot between sites, which may have been due to cul-
tural differences, habits etc. creating different attitudes to an LED
between the sites. However, site differences were to some
degree accounted for by including site as random effect in all
statistical analyses.
Conclusion
Protein intake in the range 1·0–1·6 g protein/d per kg FFM at
baseline for men and 1·1–2·2 g protein/d per kg FFM at baseline
for women was not associated with the degree of weight lost as
FFM. Higher level of TFEQ hunger at baseline and reductions in
TFEQ disinhibition and hunger during the LED were associ-
ated with larger weight loss. Lower sleep quality at baseline
predicted less successful weight loss using ITT analysis, pos-
sibly driven by those dropping out. Further investigations of
optimal protein content of LED as well as behavioural charac-
teristics potential to modify the chance of success to obtain a
weight loss with an LED are needed. Especially further inves-
tigations of different eating behaviour characteristics seem
promising in order to identify expected weight loss success
as well as the individuals in need for additional support during
an LED.
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